Patient-Harm Narrative Clusters Are Sector-Short by Default - But They're Already Spreading
The Opportunity
The system is SHORT the pharma proxy (IHE) off a broad patient-harm/safety narrative cluster. Mechanically, these clusters tend to be bearish for sector risk premia: they invite regulator attention, plaintiff activity, and payer caution. But routing is the message: this sits in propagation_monitor with a spreading lifecycle and DECAYING edge, meaning it is not a quiet informational dislocation. It is a widely circulating narrative that can still pressure sentiment, but you are not early.
The Timing
INVESTIGATE is appropriate because the edge is closing and crosswind risk is high (68). In a Mixed 58 tape, sector proxies can rally and sell off on rates and flows while safety narratives churn in the background. The timing conversion condition is the appearance of a single, anchored artefact (a safety communication, an enforcement action, a named product cohort) that collapses the narrative into a discrete list of affected issuers. Without that, you are trading "noise density," not a catalyst.
The Evidence
Upstream 6B evidence for ED-003 includes Tier-1 domains (for example reuters.com , nytimes.com , washingtonpost.com ) alongside official sources like doj.gov and fda.gov . That domain mix is exactly why the system marks the edge as decaying. The 7A object here does not provide hydrated URLs for the cluster components, so you should treat the signal as "already mainstream enough to be priced as a risk factor," not as a new discovery.